Penumbra, Inc. (PEN)
NYSE: PEN · IEX Real-Time Price · USD
199.19
-2.85 (-1.41%)
Apr 30, 2024, 1:28 PM EDT - Market open

Penumbra Revenue

In the year 2023, Penumbra had annual revenue of $1.06B with 24.95% growth. Revenue in the quarter ending December 31, 2023 was $284.68M with 28.69% year-over-year growth.

Revenue (ttm)
$1.06B
Revenue Growth
+24.95%
P/S Ratio
7.29
Revenue / Employee
$252,029
Employees
4,200
Market Cap
7.70B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.06B211.39M24.95%
Dec 31, 2022847.13M99.54M13.32%
Dec 31, 2021747.59M187.18M33.40%
Dec 31, 2020560.41M13.01M2.38%
Dec 31, 2019547.41M102.47M23.03%
Dec 31, 2018444.94M111.17M33.31%
Dec 31, 2017333.76M70.45M26.75%
Dec 31, 2016263.32M77.22M41.50%
Dec 31, 2015186.10M60.59M48.27%
Dec 31, 2014125.51M36.66M41.26%
Dec 31, 201388.85M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bio-Rad Laboratories 2.67B
Masimo 2.05B
Exelixis 1.83B
Inspire Medical Systems 624.80M
Intra-Cellular Therapies 464.37M
Ascendis Pharma 296.35M
Legend Biotech 285.14M
Revenue Rankings